发明名称 IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION
摘要 According to the present invention there is provided an immediate release pharmaceutical formulation comprising, as active ingredient, a compound of formula (I), wherein R1 represents C1-2#191 alkyl substituted by one or more fluoro substituents;R2 represents hydrogen, hydroxy, methoxy or ethoxy; andn represents 0, 1 or 2;or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable diluent or carrier; provided that when the activ e ingredient is other than in the form of a salt the formulation does not sole ly contain:.bullet. a solution of one active ingredient and water;.bullet. a solution of one active ingredient and dimethylsulphoxide; or.bullet. a solution of one active ingredient in a mixture of ethanol : PEG 660 12-hydro xy stearate : water 5:5:90; such formulations being of use for the treatment of a cardiovascular disorder.
申请公布号 CA2485533(A1) 申请公布日期 2003.12.11
申请号 CA20032485533 申请日期 2003.05.27
申请人 ASTRAZENECA AB 发明人 THUNE, MIKAEL;SIGFRIDSSON, CARL-GUSTAF;MAGNUSSON, ANDERS;ALAMI ABRAHMSEN, SUSANNA;INGHARDT, TORD
分类号 C07D205/04;A61K9/00;A61K9/08;A61K9/20;A61K31/397;A61K47/10;A61K47/12;A61K47/26;A61K47/40;A61P7/02;A61P9/00;A61P9/10;(IPC1-7):A61K9/00 主分类号 C07D205/04
代理机构 代理人
主权项
地址